×
About 3,805 results

ALLMedicine™ Bacterial Pneumonia Center

Research & Reviews  1,094 results

Association between IL-38 and inflammatory indicators in patients with bacterial pneumo...
https://doi.org/10.1016/j.cyto.2022.156052
Cytokine Sun X, Zhou J et. al.

Nov 15th, 2022 - IL-38, a recently discovered cytokine of IL-1 family, exerts immunoregulatory activities in multi-type inflammatory diseases. However, its expression level and underlying clinical importance for IL-38 in respiratory bacterial infections remain unk...

The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospi...
https://doi.org/10.1007/s00432-022-04419-x
Journal of Cancer Research and Clinical Oncology; Munsell MK, Fadelu T et. al.

Nov 14th, 2022 - Procalcitonin (PCT) is an inflammatory marker elevated in bacteremia and bacterial pneumonia. We aimed to assess the real-world diagnostic accuracy of PCT in hospitalized patients with malignancy. A retrospective cohort of 715 patients with cancer...

Synergistic Protection against Secondary Pneumococcal Infection by Human Monoclonal Ant...
https://doi.org/10.4049/jimmunol.2200349
Journal of Immunology (Baltimore, Md. : 1950); Gingerich AD, Royer F et. al.

Nov 10th, 2022 - Streptococcus pneumoniae persists as a leading cause of bacterial pneumonia despite the widespread use of polysaccharide-based vaccines. The limited serotype coverage of current vaccines has led to increased incidence of nonvaccine serotypes, as w...

Effects of procalcitonin on antimicrobial treatment decisions in patients with coronavi...
https://doi.org/10.1017/ice.2022.262
Infection Control and Hospital Epidemiology; Conlon ASC, Chopra Z et. al.

Nov 5th, 2022 - To describe the natural course of procalcitonin (PCT) in patients with coronavirus disease 2019 (COVID-19) and the correlation between PCT and antimicrobial prescribing to provide insight into best practices for PCT data utilization in antimicrobi...

A CNN-transformer fusion network for COVID-19 CXR image classification.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612494
PloS One; Cao K, Deng T et. al.

Oct 28th, 2022 - The global health crisis due to the fast spread of coronavirus disease (Covid-19) has caused great danger to all aspects of healthcare, economy, and other aspects. The highly infectious and insidious nature of the new coronavirus greatly increases...

see more →

Drugs  94 results see all →

Clinicaltrials.gov  109 results

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
https://clinicaltrials.gov/ct2/show/NCT03969901

Sep 16th, 2022 - The primary purpose of this study is to evaluate the safety and tolerability of imipenem/cilastatin/relebactam (IMI/REL) in participants from birth to less than 18 years of age with confirmed or suspected gram-negative bacterial infection. Partici...

Community Acquired Pneumonia in Older Adults
https://clinicaltrials.gov/ct2/show/NCT04709978

Aug 4th, 2022 - Pneumonia is the most common infectious cause of mortality in older adults. Standard practice for older adults with pneumonia involves hospitalization and antibiotics. However, recent studies suggest that a significant portion of suspected communi...

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
https://clinicaltrials.gov/ct2/show/NCT03583333

Jul 20th, 2022 - This study will evaluate the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) (MK-7655A) compared to piperacillin/tazobactam (PIP/TAZ) in the treatment of adults diagnosed with Hospital-Acquired Bacterial Pneumonia (HABP) or Ventila...

Antibiotic Therapy in Viral Airway Infections
https://clinicaltrials.gov/ct2/show/NCT05045612

Jun 21st, 2022 - In patients with positive airway sample for respiratory viruses, the investigators hypothesize that discontinuation of antibiotic therapy is safe and non-inferior to continuation of antibiotic therapy. More specifically, the investigators hypothes...

Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia
https://clinicaltrials.gov/ct2/show/NCT03996967

May 31st, 2022 - Clinical pneumonia is a leading cause of pediatric hospitalization. The etiology is generally bacterial or viral. Prompt and optimal treatment of pneumonia is critical to reduce mortality. However, adequate pneumonia management is hampered by: a) ...

see more →

News  215 results

What the RSV Surge Means for Doctors and Patients
https://www.medscape.com/viewarticle/982994

Oct 25th, 2022 - In early October, respiratory syncytial virus, or RSV, tore through Victoria Thiele's Indiana home. Her three older children had manageable symptoms. But her 8-week-old newborn ended up developing a severe case. Thiele, whose family lives in Fort ...

Iron Deficiency May Protect Against Bacterial Pneumonia
https://www.medscape.com/viewarticle/982845

Oct 21st, 2022 - Patients with iron deficiency anemia who developed bacterial pneumonia showed improved outcomes compared to those without iron deficiency anemia, based on data from more than 450,000 individuals in the National Inpatient Sample. Iron deficiency is...

Ibrutinib/Obinutuzumab Combo Elicits Durable Responses in Relapsed/Refractory CLL
https://www.onclive.com/view/ibrutinib-obinutuzumab-combo-elicits-durable-responses-in-relapsed-refractory-cll

Aug 4th, 2022 - Findings from a phase 1b trial (NCT02537613) showed that the addition of obinutuzumab (Gazyva) to ibrutinib (Imbruvica) produced a complete response (CR) rate that compared favorably with what has historically been observed with ibrutinib monother...

The Latest on Community-Acquired Pneumonia in Kids: Diagnosis and Treatment
https://www.medscape.com/viewarticle/977546

Jul 26th, 2022 - In the spring of 2022, the Pediatric Academic Society meeting sponsored an informative "Hot Topic" session reviewing practitioner dilemmas when diagnosing and treating community-acquired pneumonia (CAP). The CAP Diagnosis One of the first challeng...

COVID-19 Tied to Increased Risk for Alzheimer's, Parkinson's Disease
https://www.medscape.com/viewarticle/976244

Jun 27th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 has been associated with a threefold increased risk of Alzheimer's disease (AD) and a doubling of Parkinson's disease (PD) risk, a new st...

see more →

Patient Education  10 results see all →